Philip Laws

1.3k total citations
43 papers, 573 citations indexed

About

Philip Laws is a scholar working on Immunology, Rheumatology and Dermatology. According to data from OpenAlex, Philip Laws has authored 43 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Rheumatology and 12 papers in Dermatology. Recurrent topics in Philip Laws's work include Psoriasis: Treatment and Pathogenesis (16 papers), Systemic Lupus Erythematosus Research (8 papers) and Dermatology and Skin Diseases (8 papers). Philip Laws is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (16 papers), Systemic Lupus Erythematosus Research (8 papers) and Dermatology and Skin Diseases (8 papers). Philip Laws collaborates with scholars based in United Kingdom, Canada and United States. Philip Laws's co-authors include Helen Young, Neil H. Shear, D. Kimberley Molina, Craig Manifold, David Wampler, John McManus, Elena Pope, Richard B. Warren, Miriam Wittmann and Roni P. Dodiuk‐Gad and has published in prestigious journals such as Journal of Fluid Mechanics, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Philip Laws

37 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Laws United Kingdom 11 281 202 141 90 86 43 573
William N. Malatestinic United States 12 376 1.3× 192 1.0× 167 1.2× 22 0.2× 45 0.5× 53 516
Iñaki Pérez Spain 15 37 0.1× 33 0.2× 110 0.8× 35 0.4× 28 0.3× 29 670
James Herman United States 10 53 0.2× 64 0.3× 34 0.2× 13 0.1× 58 0.7× 17 388
Sandrine Kerbrat France 9 75 0.3× 64 0.3× 31 0.2× 23 0.3× 32 0.4× 27 349
Kavitha Goyal United States 12 828 2.9× 389 1.9× 204 1.4× 46 0.5× 130 1.5× 22 1.0k
Marios Rossides Sweden 13 96 0.3× 43 0.2× 104 0.7× 64 0.7× 109 1.3× 34 576
Aurélie Gaultier France 13 92 0.3× 100 0.5× 17 0.1× 35 0.4× 25 0.3× 44 625
Bent Windelborg Nielsen Denmark 13 183 0.7× 51 0.3× 17 0.1× 38 0.4× 17 0.2× 26 634
M.I.A. Koetsier Netherlands 12 311 1.1× 176 0.9× 59 0.4× 18 0.2× 30 0.3× 14 408
H‐C Lin Taiwan 7 123 0.4× 45 0.2× 44 0.3× 22 0.2× 15 0.2× 11 307

Countries citing papers authored by Philip Laws

Since Specialization
Citations

This map shows the geographic impact of Philip Laws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Laws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Laws more than expected).

Fields of papers citing papers by Philip Laws

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Laws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Laws. The network helps show where Philip Laws may publish in the future.

Co-authorship network of co-authors of Philip Laws

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Laws. A scholar is included among the top collaborators of Philip Laws based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Laws. Philip Laws is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meridor, Katya, Jane Freeston, Philip Laws, et al.. (2025). Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis. Lara D. Veeken. 65(3).
2.
Harrison, Stephanie R, Fiona Campbell, Hannah Bennett, et al.. (2024). High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study. British Journal of Dermatology. 191(6). 1018–1020. 1 indexed citations
3.
4.
5.
6.
7.
8.
Savic, Sinisa, et al.. (2021). Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases. Journal of Investigative Dermatology. 142(3). 781–792. 5 indexed citations
9.
Hunt, William, M.F. Mohd Mustapa, N. J. Levell, et al.. (2021). Readability assessment of the British Association of Dermatologists’ patient information leaflets. Clinical and Experimental Dermatology. 47(4). 684–691. 10 indexed citations
10.
Savage, L., Ilaria Tinazzi, Alen Zabotti, et al.. (2020). Defining Pre-Clinical Psoriatic Arthritis in an Integrated Dermato-Rheumatology Environment. Journal of Clinical Medicine. 9(10). 3262–3262. 24 indexed citations
11.
Freeston, Jane, Andrew Barr, Christian P. Selinger, et al.. (2020). Improving patient care through a collaborative effort in the Leeds Combined Psoriatic Service: an effective provision of multi-specialty input. Lara D. Veeken. 60(1). 467–470. 3 indexed citations
12.
Young, Helen, Ian Kamaly-Asl, Philip Laws, P. Pemberton, & C.E.M. Griffiths. (2019). Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis. Clinical and Experimental Dermatology. 45(3). 302–308. 6 indexed citations
13.
14.
Bridgewood, Charlie, Gareth W. Fearnley, Philip Laws, et al.. (2018). IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis. Frontiers in Immunology. 9. 200–200. 71 indexed citations
15.
Abignano, Giuseppina, Philip Laws, F. Galdo, Helena Marzo‐Ortega, & Dennis McGonagle. (2017). FRI0646 Three-dimensional nail imaging by optical coherence tomography: a novel biomarker of response to therapy for nail disease in psoriasis and psoriatic arthritis. Annals of the Rheumatic Diseases. 76. 734–734. 1 indexed citations
16.
Bridgewood, Charlie, Gareth W. Fearnley, Philip Laws, et al.. (2017). 315 IL-36y is a strong inducer of IL-23 production and angiogenesis in psoriasis. Journal of Investigative Dermatology. 137(10). S246–S246.
17.
Dodiuk‐Gad, Roni P., Philip Laws, & Neil H. Shear. (2014). Epidemiology of severe drug hypersensitivity. Seminars in Cutaneous Medicine and Surgery. 33(1). 2–9. 36 indexed citations
18.
Laws, Philip & Helen Young. (2012). Current and Emerging Systemic Treatment Strategies for Psoriasis. Drugs. 72(14). 1867–1880. 37 indexed citations
19.
Laws, Philip, Anthony M. Downs, Richard Parslew, et al.. (2011). Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland. British Journal of Dermatology. 166(1). 189–195. 29 indexed citations
20.
Laws, Philip & Helen Young. (2010). Topical treatment of psoriasis. Expert Opinion on Pharmacotherapy. 11(12). 1999–2009. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William N. Malatestinic Breakdown of academic impact, for papers by Iñaki Pérez Breakdown of academic impact, for papers by James Herman Breakdown of academic impact, for papers by Sandrine Kerbrat Breakdown of academic impact, for papers by Kavitha Goyal Breakdown of academic impact, for papers by Marios Rossides Breakdown of academic impact, for papers by Aurélie Gaultier Breakdown of academic impact, for papers by Bent Windelborg Nielsen Breakdown of academic impact, for papers by M.I.A. Koetsier Breakdown of academic impact, for papers by H‐C Lin
Rankless by CCL
2026